These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 36050287)
1. Haloperidol Prevents Oxytosis/Ferroptosis by Targeting Lysosomal Ferrous Ions in a Manner Independent of Dopamine D2 and Sigma-1 Receptors. Hirata Y; Oka K; Yamamoto S; Watanabe H; Oh-Hashi K; Hirayama T; Nagasawa H; Takemori H; Furuta K ACS Chem Neurosci; 2022 Sep; 13(18):2719-2727. PubMed ID: 36050287 [TBL] [Abstract][Full Text] [Related]
2. Identification of novel neuroprotective N,N-dimethylaniline derivatives that prevent oxytosis/ferroptosis and localize to late endosomes and lysosomes. Hirata Y; Tsunekawa Y; Takahashi M; Oh-Hashi K; Kawaguchi K; Hayazaki M; Watanabe M; Koga KI; Hattori Y; Takemori H; Furuta K Free Radic Biol Med; 2021 Oct; 174():225-235. PubMed ID: 34407426 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of double-stranded RNA-dependent protein kinase prevents oxytosis and ferroptosis in mouse hippocampal HT22 cells. Hirata Y; Iwasaki T; Makimura Y; Okajima S; Oh-Hashi K; Takemori H Toxicology; 2019 Apr; 418():1-10. PubMed ID: 30817950 [TBL] [Abstract][Full Text] [Related]
5. Haloperidol, a sigma receptor 1 antagonist, promotes ferroptosis in hepatocellular carcinoma cells. Bai T; Wang S; Zhao Y; Zhu R; Wang W; Sun Y Biochem Biophys Res Commun; 2017 Sep; 491(4):919-925. PubMed ID: 28756230 [TBL] [Abstract][Full Text] [Related]
6. Antiferroptotic Activities of Oxindole GIF-0726-r Derivatives: Involvement of Ferrous Iron Coordination and Free-Radical Scavenging Capacities. Takahashi M; Hamamoto A; Oh-Hashi K; Takemori H; Furuta K; Hirata Y ACS Chem Neurosci; 2023 May; 14(10):1826-1833. PubMed ID: 37104649 [TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of Brazilian green propolis on oxytosis/ferroptosis in mouse hippocampal HT22 cells. Takashima M; Ichihara K; Hirata Y Food Chem Toxicol; 2019 Oct; 132():110669. PubMed ID: 31299294 [TBL] [Abstract][Full Text] [Related]
8. Future Perspectives of Oxytosis/Ferroptosis Research in Neurodegeneration Diseases. Viktorinova A Cell Mol Neurobiol; 2023 Aug; 43(6):2761-2768. PubMed ID: 37093436 [TBL] [Abstract][Full Text] [Related]
9. Neuroleptics with differential affinities at dopamine D2 receptors and sigma receptors affect differently the N-methyl-D-aspartate-induced increase in intracellular calcium concentration: involvement of protein kinase. Hayashi T; Su TP; Kagaya A; Nishida A; Shimizu M; Yamawaki S Synapse; 1999 Jan; 31(1):20-8. PubMed ID: 10025680 [TBL] [Abstract][Full Text] [Related]
10. Oxytosis/Ferroptosis-(Re-) Emerging Roles for Oxidative Stress-Dependent Non-apoptotic Cell Death in Diseases of the Central Nervous System. Lewerenz J; Ates G; Methner A; Conrad M; Maher P Front Neurosci; 2018; 12():214. PubMed ID: 29731704 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the effects of the enantiomers of reduced haloperidol, azaperol, and related 4-amino-1-arylbutanols on dopamine and sigma receptors. Jaen JC; Caprathe BW; Pugsley TA; Wise LD; Akunne H J Med Chem; 1993 Nov; 36(24):3929-36. PubMed ID: 7902870 [TBL] [Abstract][Full Text] [Related]
13. [Effects of serotonergic drugs on the up-regulation of dopamine D2 receptors induced by haloperidol in rat striatum]. Ishikane T Hokkaido Igaku Zasshi; 1998 Sep; 73(5):441-9. PubMed ID: 9846274 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and Pharmacological Characterization of a Difluorinated Analogue of Reduced Haloperidol as a Sigma-1 Receptor Ligand. Gao RD; Taylor M; McInnis T; Chen Z; Gori SS; LaPorte HM; Siegler MA; Neisewander JL; Mach RH; Singh M; Slusher BS; Rais R; Luedtke RR; Tsukamoto T ACS Chem Neurosci; 2023 Mar; 14(5):947-957. PubMed ID: 36780706 [TBL] [Abstract][Full Text] [Related]
15. First-Generation Antipsychotic Haloperidol Alters the Functionality of the Late Endosomal/Lysosomal Compartment in Vitro. Canfrán-Duque A; Barrio LC; Lerma M; de la Peña G; Serna J; Pastor O; Lasunción MA; Busto R Int J Mol Sci; 2016 Mar; 17(3):404. PubMed ID: 26999125 [TBL] [Abstract][Full Text] [Related]
17. Prototypical antipsychotic drugs protect hippocampal neuronal cultures against cell death induced by growth medium deprivation. Bastianetto S; Danik M; Mennicken F; Williams S; Quirion R BMC Neurosci; 2006 Mar; 7():28. PubMed ID: 16573831 [TBL] [Abstract][Full Text] [Related]
18. F15063, a potential antipsychotic with dopamine D(2)/D(3) antagonist, 5-HT(1A) agonist and D(4) partial agonist properties: (IV) duration of brain D2-like receptor occupancy and antipsychotic-like activity versus plasma concentration in mice. Assié MB; Bardin L; Auclair A; Consul-Denjean N; Sautel F; Depoortère R; Newman-Tancredi A Naunyn Schmiedebergs Arch Pharmacol; 2007 Jun; 375(4):241-50. PubMed ID: 17453175 [TBL] [Abstract][Full Text] [Related]
19. Lack of dopamine supersensitivity in rats after chronic administration of blonanserin: Comparison with haloperidol. Hashimoto T; Baba S; Ikeda H; Oda Y; Hashimoto K; Shimizu I Eur J Pharmacol; 2018 Jul; 830():26-32. PubMed ID: 29684390 [TBL] [Abstract][Full Text] [Related]
20. Melatonin prevents glutamate-induced oxytosis in the HT22 mouse hippocampal cell line through an antioxidant effect specifically targeting mitochondria. Herrera F; Martin V; García-Santos G; Rodriguez-Blanco J; Antolín I; Rodriguez C J Neurochem; 2007 Feb; 100(3):736-46. PubMed ID: 17263795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]